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Axonal degeneration arises as a consequence of
neuronal injury and is a common hallmark of a
number of neurodegenerative diseases. However,
the genetic causes and the cellular mechanisms
that trigger this process are still largely unknown.
Based on forward genetic screening in C. elegans,
we have identified the a-tubulin acetyltransferase
gene mec-17 as causing spontaneous, adult-onset,
and progressive axonal degeneration. Loss of
MEC-17 leads to microtubule instability, a reduction
in mitochondrial number, and disrupted axonal
transport, with altered distribution of both mito-
chondria and synaptic components. Furthermore,
mec-17-mediated axonal degeneration occurs inde-
pendently from its acetyltransferase domain; is
enhanced by mutation of coel-1, a tubulin-associ-
ated molecule; and correlates with the animal’s
body length. This study therefore identifies a critical
role for the conserved microtubule-associated pro-
tein MEC-17 in preserving axon integrity and pre-
venting axonal degeneration.
INTRODUCTION
Maintenance of axonal structure is critical for neuronal function.
Under normal conditions, the axon is maintained in a healthy
state through a constant supply of materials via its attachment
to the cell body. This connection is lost after nerve injury and
becomes compromised in a number of neurodegenerative
diseases, leading to degeneration of the axon (Coleman, 2005;
Raff et al., 2002). Specific cellular mechanisms that have been
linked to axonal degeneration include deficits in axonal trans-
port, mitochondrial dysfunction, increase in intra-axonal
calcium, and calcium-dependent cytoskeletal breakdown (Cole-
man, 2005; Hilliard, 2009;Wang et al., 2012). Amajor component
of the cytoskeleton is formed by the microtubules, cylindrical
structures assembled from chains of a- and b-tubulin hetero-
dimers termed protofilaments (Desai and Mitchison, 1997).
These highly dynamic structures are essential for many cellular
functions, including intracellular transport and organelle posi-tioning, as well as cell division and polarity (Westermann and
Weber, 2003). Microtubules are subjected to a wide range of
posttranslational modifications, including acetylation (Janke
and Bulinski, 2011), the major site of which occurs on lysine 40
of a-tubulin inside the microtubule lumen (Nogales et al.,
1998). Although it has largely been considered as a passive
marker of stable microtubules (Hammond et al., 2008), several
studies have postulated that acetylation of a-tubulin is required
for efficient axonal transport, allowing greater binding andmove-
ment of motor proteins (Cai et al., 2009; d’Ydewalle et al., 2011;
Dompierre et al., 2007; Hammond et al., 2010; Konishi and
Setou, 2009; Reed et al., 2006). Loss or reduction in the levels
of acetylated a-tubulin has also been associated with a number
of pathological conditions, including familial dysautonomia and
Alzheimer’s, Huntington’s, and Charcot-Marie-Tooth diseases
(d’Ydewalle et al., 2011; Dompierre et al., 2007; Gardiner et al.,
2007; Hempen and Brion, 1996).
Despite acetylation of K40 first being described in 1985
(L’Hernault and Rosenbaum, 1985), the identity of the a-tubulin
acetyltransferase enzyme and the precise functional conse-
quence of the modification remained unresolved until recently,
when MEC-17/aTAT1 was identified as the acetylating enzyme
conserved across all ciliated organisms (Akella et al., 2010;
Shida et al., 2010). Significant insights into its function have
now emerged, with two recent studies in C. elegans demon-
strating that MEC-17 is critical for microtubule organization,
stabilizing their number and length, and defining protofilament
number (Cueva et al., 2012; Topalidou et al., 2012). Furthermore,
Cueva et al. (2012) propose that K40 acetylation promotes the
formation of stabilizing salt bridges between protofilaments,
thereby creating structural supports within the microtubule
lumen. In spite of the apparent importance of MEC-17, only a
fewmorphological alterations have been linked to its loss. These
include an increase in microtubule dynamics in Tetrahymena
(Akella et al., 2010), a progressive loss of mechanosensory
neuron function and minor neurite outgrowth defects in
C. elegans (Topalidou et al., 2012; Zhang et al., 2002), and
behavior consistent with neuromuscular defects in zebrafish
(Akella et al., 2010). In C. elegans, MEC-17 is expressed solely
in the sixmechanosensory neurons (Zhang et al., 2002) and func-
tions redundantly with its more broadly expressed paralog,
ATAT-2 (Akella et al., 2010; Shida et al., 2010).
Here, we show that MEC-17 is critical for maintaining axonal
structure, with mutations causing spontaneous, adult-onset,Cell Reports 6, 93–103, January 16, 2014 ª2014 The Authors 93
Figure 1. Identification and Mapping of the
ky850 Mutation
(A) Image and schematic of a wild-type
zdIs5(Pmec-4::GFP) larval-stage four (L4) animal,
illustrating the six mechanosensory neurons
(PLML/R, PVM, ALML/R, and AVM). Anterior is left
and ventral is down in this and all subsequent
images.
(B) Image and schematic of a typical intact PLM
neuron from a 3-day-old adult wild-type animal
(B1) and that of a typical axon break (bracketed
region) in a 3-day-old adult ky850 mutant (B2).
(C) Axonal breaks quantified in mec-17(ok2109)
animals of progressive ages. Similar results were
obtained for mec-17(u265) animals (data not
shown). DOA, day-old adult.
(D) Penetrance of axonal breaks in ky850, QH4387
(33 outcrossed ky850), and mec-17(ok2109)
animals, carrying the Pmec-4::mec-17 rescue
transgene versus nontransgenic siblings.
(E) Penetrance of axonal degeneration in ky850
(black bar) animals and the different mec-17
alleles (gray bars). F1 cross progeny (white bars)
were analyzed for phenotypic complementation.
The scale bars represent 25 mm; error bars
represent SE of proportion; n R 100 animals;
***p < 0.001.and progressive axonal degeneration in C. elegans. This pheno-
type is independent of the role of MEC-17 in acetylating
a-tubulin, as an enzymatically inactive version retains the ability
to protect axons from degeneration. Loss of MEC-17 disrupts
axonal transport, causing a decrease in the number and spatial
arrangement of axonal mitochondria and an altered distribution
of presynaptic loci. We find that MEC-17 functions in synergy
with the microtubule-associated protein COEL-1 to stabilize
microtubules and protect from axon fragility. Furthermore, our
results establish that axonal degeneration can be strongly
enhanced by elongation of the axonal shaft resulting from
increased body length.
RESULTS
Isolation of the ky850 Strain with Axonal Degeneration
To identify factors required for the maintenance of axonal struc-
ture, we performed forward genetic screens using a C. elegans
strain expressing GFP in the six mechanosensory neurons
(PLML/R, PVM, ALML/R, and AVM; Figure 1A). This wild-type
strain, carrying the transgene zdIs5(Pmec-4::GFP), effectively
displays no axonal degeneration (Figure S1A). We visually
screened for animals displaying spontaneous axonal degenera-
tion and identified the recessive ky850 mutation as presenting
GFP interruptions (axonal breaks) in the PLM, ALM, and AVM94 Cell Reports 6, 93–103, January 16, 2014 ª2014 The Authorsaxons (Figure 1B). Degeneration of the
separated distal fragments occurred in a
stereotypical Wallerian-like fashion, with
thinning, beading, and fragmentation
occurring over the 24–96 hr following
the initial breaks, but did not lead to
a ‘‘die-back’’ phenotype. The defectappeared selectively in adult animals (adult-onset), and the
penetrance increased progressively with age, reaching a
maximum of 45% in PLM (Figure S1B). ky850 animals displayed
a deficit in their response to gentle mechanical stimuli (light-
touch assay) applied to either their head or tail, indicating that
both the anterior and posterior mechanosensory circuits (medi-
ated by ALMs/AVM and PLMs, respectively) were dysfunctional
(Figure S1C). In addition to axonal degeneration, we observed
axonal outgrowth defects in ky850 animals that appeared during
development and worsened with age (Figures S1D and S1E).
The ky850 Mutation Is an Allele ofmec-17
Several lines of evidence revealed that ky850 is an allele of the
a-tubulin acetyltransferase gene mec-17. First, direct mapping
from whole-genome sequencing data (Zuryn et al., 2010) re-
vealed a strong peak on chromosome IV at the precise location
of mec-17 (Figure S1F), and we identified a C-T transition at
nucleotide position 79 of the gene, resulting in the introduction
of a stop codon in the encoded protein, truncating MEC-17
from 262 amino acids to 26 (Figure S1G). Second, cell-
autonomous expression of wild-type MEC-17 in the mechano-
sensory neurons (using a Pmec-4::mec-17 transgene) provided
strong rescue of the degenerative phenotype (Figure 1D). Third,
two other alleles of mec-17 (ok2109 and u265; Figure S1G) also
presented with progressive, adult-onset axonal breaks in the
Figure 2. mec-17Mutants Display a Reduc-
tion in Axonal Mitochondria and a Clus-
tering toward the Cell Body
(A and B) Image and schematic of mitochondria in
PLM in both wild-type (A) and mec-17(ok2109)
(B) 3-day-old adults. Mitochondria (arrowheads)
were visualized with the vdEx484[Pmec-4::tomm-
20::mRFP] transgene. (B1 and B2) Magnified view
of the corresponding regions in themec-17mutant
animal to highlight faint mitochondria.
(C) Average number of mitochondria in PLM in
wild-type and mec-17(ok2109) animals.
(D) Quantification of mitochondria in proximal
(closest third to the cell body), central (middle
third), and distal (final third) regions of the PLM
axon in L4 and 3-day-old adults.
(E) Average number of mitochondria in the PLM
posterior neurite in wild-type andmec-17(ok2109)
animals.
The scale bars represent 25 mm; the error bars
represent SEM; *p < 0.05; **p < 0.01; ***p < 0.001;
nR 26 animals.mechanosensory neurons (Figure 1C). However, although the
axon breaks were morphologically identical, the penetrance of
degeneration in these strains was lower than in animals with
the ky850mutation (21% compared to 45% in 5-day-old adults).
This discrepancy is likely due to a background effect of additional
mutations in the ky850 strain, as outcrossing ky850 reduced the
penetrance of axonal degeneration to levels similar to those in
mec-17(ok2109) animals (Figures 1D and 1E). Importantly, cell-
autonomous expression of wild-type MEC-17 in either this
outcrossed ky850 strain (QH4387) or in the mec-17(ok2109)
strain strongly rescued the degeneration observed in the PLM
axon (Figure 1D). As previously described (Topalidou et al.,
2012), the two othermec-17 alleles displayed outgrowth defects
in PLM and ALM, which were similar to those of ky850 mutants,
but again to a lower penetrance (Figure S1E). Finally, aswe found
all three alleles ofmec-17 (ky850, ok2109, and u265) to be reces-
sive (no axonal degeneration in heterozygous animals; n > 100),
we conducted complementation analyses of ky850 or the
outcrossed ky850 strain (QH4387) with ok2109 and u265, which
revealed noncomplementation (Figure 1E), thereby confirming
that the three mutations are alleles of the same gene.Cell Reports 6, 93–10Loss ofmec-17 Leads to Disruption
of Mitochondria and Axonal
Transport
To characterize the intra-axonal mecha-
nisms disrupted by loss of MEC-17
function, we first analyzed mitochondria
using a fluorescently tagged version of
the translocase of outer mitochondrial
membrane 20 protein (Kanaji et al.,
2000; Figure 2A). The average number
of mitochondria in mec-17 (ok2109)
animals was reduced compared to wild-
type at both the L4 and adult stages
(Figures 2A–2C). Furthermore, mec-
17(ok2109) animals displayed a strikingdisruption in the localization of their mitochondria. Wild-type
animals presented a relatively even distribution of mitochondria
in the PLM axon in the L4 stage and a slightly skewed distribution
toward the cell body in adulthood (Figure 2D). In contrast, mec-
17(ok2109) animals had a skewed distribution of mitochondria at
the L4 stage, with a reduced number of mitochondria in the distal
segment. This defect was severely enhanced in adult animals,
with the distal segment becoming largely devoid of mitochondria
(Figures 2B and 2D). Interestingly, it was in these distal regions
with reduced mitochondrial number that we observed the
majority of the axonal breaks. In addition, we found that
mec-17(ok2109) animals had a large increase in the number of
mitochondria localized in the posterior PLM neurite (Figure 2E),
corresponding to the additional outgrowth defects observed in
mec-17 mutants. We also observed similar mitochondrial
defects in ALM neurites (Figures S2A–S2C). Taken together,
these results uncover a critical role of MEC-17 in regulating the
number and localization of mitochondria in the mechanosensory
neurons.
A possible explanation for the mitochondrial defects is a
disruption in axonal transport. We analyzed a fluorescently3, January 16, 2014 ª2014 The Authors 95
Figure 3. mec-17 Animals Display Aberrant
Axonal Transport
(A and B) Image and schematic of UNC-104/
kinesin-3 in PLM of wild-type (A) and mec-
17(ok2109) (B) 3-day-old adult animals used to
monitor axonal transport. UNC-104 was visualized
using the jsIs1111[Pmec-4::unc-104::GFP] trans-
gene. Insets show a magnified view of the distal
axon tips. Arrowheads point to the distal tip of the
PLM axon. The scale bars represent 25 mm.
(C) Quantification of UNC-104::GFP localization in
PLM in wild-type and mec-17(ok2109) animals.
Anterior neurite defined as per image shown in (A),
with anterior localization and accumulation at
presynaptic sites. Gray bars indicate additional
localization in the PLM posterior neurite. White
bars designate localization in both the anterior
and posterior neurites with no presynaptic
accumulation.
(D) Comparison of the number of animals dis-
playing UNC-104::GFP pooling at the distal end of
the PLM axon.
(E) Accumulation of UNC-104::GFP measured in
different regions along the PLM axon in wild-type
and mec-17(ok2109) animals at the L4 stage and
in 3-day-old adults. This analysis excludes pooling
at the distal tip.
The error bars represent SE of proportion;
*p < 0.05; ***p < 0.001; nR 51 animals.tagged version of UNC-104/kinesin-3 (Kumar et al., 2010), one of
the main motor molecules responsible for transport of synaptic
vesicles to presynaptic loci (Hall and Hedgecock, 1991). Wild-
type animals exhibited a consistent distribution of fluorescence
in PLM, with a smooth increase in expression along the axon in
a proximal-to-distal fashion, and pooling at the distal end and
at presynaptic sites (Figure 3A). By comparison, the vastmajority
of mec-17(ok2109) mutant animals displayed a bipolar distri-
bution, with strong expression also observed in the posterior
neurite (Figures 3B and 3C), and approximately 7% of animals
completely lacked expression of UNC-104 at the presynaptic
loci of PLM (Figure 3C). Furthermore, more than 25% of animals
lacked accumulation at the distal end of the axon (Figure 3D) and
instead displayed accumulation of bright puncta along more
proximal sections of the axon (Figure 3E), indicative of disrupted
axonal transport. To correlate these findings with localization of
presynaptic components, we studied the distribution of the
synaptic vesicle-associated small guanosine triphosphatase,
RAB-3 (Nonet et al., 1997). Expression of RAB-3 in wild-type96 Cell Reports 6, 93–103, January 16, 2014 ª2014 The Authorsanimals was strongly localized to the
presynaptic terminals and only weakly
within the cell body and proximal anterior
axon (Figure 4A). On the contrary, 24% of
mec-17(ok2109) mutant animals com-
pletely lacked expression of RAB-3 at
the presynaptic sites of PLM (Figure 4C).
Similar to the distribution of UNC-104,
we also observed bipolar distribution of
RAB-3 in mec-17(ok2109) animals, with
clusters visible in the ends of the posteriorneurite (Figures 4B and 4C). Similar deficits in the localization of
UNC-104 and RAB-3 were observed in ALM neurons ofmec-17
mutants (Figures S2D and S2E).
Collectively, these findings suggest that, in the absence of
MEC-17, axonal transport is defective, and as a result, the
localization of presynaptic components and the number and
distribution of mitochondria are disrupted, culminating in degen-
eration of the axon.
MEC-17-Mediated Acetylation of MEC-12 Is Not
Required for Axonal Maintenance
MEC-17 has been demonstrated to function redundantly with its
paralog, ATAT-2, in the acetylation of MEC-12/a-tubulin (Akella
et al., 2010; Shida et al., 2010). To determine if ATAT-2 is also
required in the maintenance of axonal structure, we analyzed
atat-2(ok2415) animals, which have a deletion eliminating almost
60%of the atat-2 transcript. Single mutants displayed no degen-
erative phenotype in the mechanosensory neurons, and double
mutants with mec-17 were not different from mec-17 single
Figure 4. mec-17 Animals Display Aberrant
Localization of Presynaptic Components
(A and B) Image and schematic of PLM presyn-
aptic loci in wild-type (A) and mec-17(ok2109)
(B) 3-day-old adult animals visualized using
the vdEx262[Pmec-4::mCherry::rab-3] transgene.
Arrowheads point to presynaptic sites; arrow
points to accumulation in the posterior neurite.
The scale bars represent 25 mm.
(C) Localization of mCherry::RAB-3 analyzed in
wild-type and mec-17(ok2109) animals. Anterior
refers to localization in the anterior neurite (as in A);
posterior refers to localization in the posterior
neurite (as in B). nR 52 animals.mutants (Figure S3A), demonstrating that ATAT-2 does not
function in axonal maintenance in these neurons. Next, to deter-
mine if the acetyltransferase domain of MEC-17 is needed for
axonal maintenance, we generated a mutant version (MEC-17
[D144N]) lacking the ability to acetylate MEC-12/a-tubulin (Shida
et al., 2010; Topalidou et al., 2012) and introduced it selectively in
the mechanosensory neurons of mec-17 mutant animals. As
shown in Figure 5A, this version of MEC-17 could still rescue
axonal breakage. Moreover, this acetyltransferase-dead version
of MEC-17 could also completely rescue the mitochondrial dis-
tribution defect observed in mec-17(ok2019) mutant animals
(Figures 5B and S3B), demonstrating that the acetyltransferase
domain is not required for MEC-17 to prevent axonal degenera-
tion. To determine whether MEC-12/a-tubulin functions in the
mec-17-mediated degenerative phenotype, we studied animals
carrying mutations in the mec-12 gene. Two different alleles of
mec-12 (either u63 or u241; Figure S3C) generated a highly
penetrant, largely adult-onset, and severe degenerative pheno-
type in all six mechanosensory neurons (Figures 5C and S3E–
S3G). Axonal degeneration of PLM in the double mutants with
mec-17 showed an allele-dependent effect (increased degener-
ationwith u63 and decreasedwith the dominant allele u241) con-
firming the functional interaction between MEC-17 and MEC-12.
Interestingly, loss of function of the other microtubule subunit,
MEC-7/b-tubulin, also caused severe axonal degeneration in
the mechanosensory neurons (Figures 5D, S3D, and S3H) thatCell Reports 6, 93–10was exacerbated by mutation in mec-
17, again indicating functional synergy.
Furthermore, we found similar defects in
the distribution of mitochondria in mec-
12 and mec-7 mutant animals as those
in mec-17 mutants (Figures S3I and
S3J). To further investigate the role of
the MEC-17 acetyltransferase domain in
axonal degeneration, we analyzed a
mutant version of MEC-12 that could
not be acetylated at the K40 site (K40R;
Akella et al., 2010). As shown in Figure 5E,
MEC-12(K40R) could rescue the degen-
eration observed in mec-12(e1607) ani-
mals to similar levels as wild-type (WT)
MEC-12. Finally, we found that MEC-
12(K40R) animals display mitochondriaalong the PLM axon as per WT animals (Figures 5B and S3B).
Together, these data conclusively demonstrate that acetylation
of MEC-12 is redundant for MEC-17’s role in maintaining axonal
structure and reveal a critical role for each microtubule subunit,
MEC-12/a-tubulin and MEC-7/b-tubulin, in maintaining axonal
integrity after development.
Mutation ofmec-17 Leads to Microtubule Instability
Although the acetylation activity of MEC-17 was not required for
its function in axonal maintenance, our results with MEC-12 and
MEC-7 suggested that loss of mec-17 might negatively affect
microtubule stability. To directly visualize microtubule dynamics
in PLM, we analyzed a GFP-tagged version of end-binding pro-
tein 2 (EBP-2), a marker of plus-end-growing microtubules
(Srayko et al., 2005). As the majority of EBP-2::GFP ‘‘comets’’
(growing microtubules) have previously been demonstrated to
occur close to the cell body under resting conditions (Ghosh-
Roy et al., 2012), we used spinning-disk confocal microscopy
and kymographs to analyze the initial 25 mm of the PLM axon
(Figures 6A and 6B; Movie S1). Remarkably, as shown in Fig-
ure 6C and Movie S2, animals carrying the mec-17(ok2109)
mutation displayed a 2-fold increase in the number of growing
microtubules compared to WT animals. Moreover, whereas the
vast majority of microtubules grew in the anterograde direction
in WT animals, mec-17(ok2109) mutants presented a signifi-
cantly higher proportion of EBP-2::GFP comets moving in the3, January 16, 2014 ª2014 The Authors 97
Figure 5. MEC-17 Acetyltransferase Ac-
tivity Is Not Required for Axonal Mainte-
nance
(A) Expression of MEC-17 lacking acetyltrans-
ferase activity from the Pmec-4::mec-17(D144N)
transgene rescues the axonal degeneration
phenotype in ky850, QH4387 (33 outcrossed
ky850), and mec-17(ok2109) animals, compared
to their nontransgenic siblings.
(B) Expression of the Pmec-4::mec-17(D144N)
transgene rescues the mitochondrial distribution
defect found in 3-day-old adult mec-17(ok2109)
animals, restoring their localization to the WT
pattern. MEC-12(K40R) (lacking acetylation
residue) animals display a normal distribution of
mitochondria.
(C) Quantification of axonal degeneration (L4
stage) in animals carrying single and double
mutations in MEC-17 and MEC-12/a-tubulin.
(D) Comparison of axonal degeneration (L4 stage)
in mec-17 and mec-7 (encoding b-tubulin) single
and double mutants.
(E) Rescue of PLM axonal degeneration in mec-
12(e1607) animals with WT MEC-12 or with the
MEC-12(K40R) mutated version.
The error bars represent SE of proportion
(A and C–E) and SE (B); *p < 0.05; **p < 0.01; ***p <
0.001; n R 100 animals (A and C–E) and R24
animals (B).retrograde direction (Figure 6D). Whereas no changes in micro-
tubule track length, growth duration, or catastrophe frequency
were observed, the velocity of microtubule growth was sig-
nificantly reduced in adult mec-17(ok2109) animals (Figures
S4A–S4D). These data indicate that loss of MEC-17 function
leads to a destabilization of the microtubule network, causing a
greater frequency of microtubule growth and disrupting microtu-
bule polarity within the axon.
We extended our analyses of microtubule stability by treating
animals with microtubule-stabilizing (paclitaxel) or -destabilizing
(colchicine) compounds (Fojo, 2008). Treatment of mec-17
mutants with paclitaxel led to a more than 6-fold decrease in
the penetrance of PLM axonal degeneration (Figures 6E, S4E,
S4G, and S4H). Next, using a concentration that had no effect
on wild-type animals, we treated mec-17 mutants with colchi-
cine and found a more than 5-fold increase in axonal degenera-
tion (Figures 6E and S4F–S4H). Interestingly, the mitochondrial
distribution defects observed in mec-17 mutants (Figure 2D)
were rescued with paclitaxel treatment and exacerbated by
colchicine (Figures S4I and S4J), supporting a correlation
betweenmitochondrial mislocalization and axonal degeneration.
We further tested the effect of mec-17 mutation on axonal
stability by investigating the genetic interaction between mec-
17 and coel-1. COEL-1 is homologous to the tubulin-folding
cofactor E-like molecule, which is involved in tubulin stability
(Bartolini et al., 2005). Mutation of coel-1 by itself was not suffi-
cient to induce a degenerative phenotype in the mechano-
sensory neurons and did not present an altered distribution of
mitochondria (Figures 6F and S5A–S5C). However, when com-
bined with mutation of mec-17, we observed a 2-fold enhance-98 Cell Reports 6, 93–103, January 16, 2014 ª2014 The Authorsment in the penetrance of axonal breaks in both PLM and AVM
(Figure 6F), demonstrating a genetic interaction between the
two genes.
Finally, to determine if MEC-17-induced axon degeneration
was due to an acquired axonal fragility, we investigated the
effect of physical tension from the animal’s movement on axonal
structure. We analyzed mec-17 mutant animals paralyzed by
RNAi against unc-54, the gene encoding the major C. elegans
myosin heavy chain (MacLeod et al., 1977). Paralysis of mec-
17 mutants induced a strong suppression of axonal degenera-
tion (Figure 6G), indicating that the mechanical stress applied
to the axons by simple body movement was sufficient to cause
spontaneous breaks. These results support a model in which
MEC-17 acts to stabilize the microtubules so as to prevent the
axon becoming vulnerable to physical strain.
Body Length Correlates with Axonal Degeneration
In outcrossing the ky850 mutant animals, we serendipitously
identified amutant animal with an elongated body (LONg pheno-
type), which displayed a significant increase in the number of
axonal breaks. We mapped and cloned this spontaneous muta-
tion and found it to be an allele (vd037) of the gene lon-3 (encod-
ing for a cuticle collagen; Nystro¨m et al., 2002). A second known
lon-3 allele (e2175) was also able to significantly enhance the
axonal degeneration phenotype of mec-17 mutants (Figure 7).
To test if the enhancement of axonal degeneration was caused
by the specific disruption of lon-3, or more generically by the
longer body shape, we analyzed other mutant strains displaying
similar elongated morphology (Figures 7 and S6A). We studied
another two conserved genes from the transforming growth
Figure 6. Loss of mec-17 Causes Microtubule Instability and Axon
Fragility
(A) A representative image of PLM in a L4 WT animal carrying the Pmec-
4::ebp-2::GFP transgene that highlights the 25 mm region of interest (ROI)
analyzed in the kymograph shown below the image. Schematic adjacent to
kymograph illustrates how comets were traced and measured for growth
length and duration. White arrows point to comets growing in the anterograde
direction.
(B) Representative image of EBP-2::GFP expressed in PLM of a mutant mec-
17(ok2109) L4 animal, with an increased number of microtubule comets, as
evident in the kymograph below the image. White arrows point to comets
growing in the anterograde direction; red arrows to those in the retrograde
direction. For both (A) and (B), the scale bar in the images represents 10 mm;
scale bars in the kymographs represent 10 mm for the x axis, and 10 s for the
y axis.
(C) Mutation ofmec-17(ok2109) causes a significant increase in the number of
EBP-2::GFP comets compared toWT in L4 and 3-day-old adult animals. n = 15
animals for WT, and nR 11 for mec-17(ok2109).
(D) EBP-2::GFP comets grow significantly more in the retrograde direction
in both L4 and 3-day-old adult mec-17(ok2109) mutants compared to WT.
nR 25 comets for WT and nR 69 for mec-17(ok2109).
(E) mec-17(ok2109) animals were grown on control agar containing
1% DMSO or agar containing either 1 mM paclitaxel (microtubule stabilizer)
or 0.1 mM colchicine (microtubule destabilizer) and scored as 2-day-
old adults.factor b (TGF-b)-like-signaling pathway, lon-1 (a pathogenesis-
related protein; Morita et al., 2002) and lon-2 (a glypican;
Gumienny et al., 2007), as well as the TGF-b-signaling indepen-
dent gene, lon-8 (Soete et al., 2007). Mutations in these genes
caused a mild axonal degenerative phenotype (Figure S6B).
However, when combined with the mec-17(ok2109) mutation,
all four genes caused a remarkable increase in axonal degener-
ation (Figure 7).
We postulated that this enhancement in degeneration could
be due to the increased demands placed upon the cell body in
order to maintain a significantly longer axon. To test this hypoth-
esis, we analyzed shorter animals to determine if axonal degen-
eration was suppressed. As previously described, mutation of
the genes sma-3 (a receptor-regulated Smad), sma-4 (a Smad
protein), sma-6 (a TGF-b-like type I receptor), and dbl-1
(a bone-morphogenic-protein-like TGF-b-signaling molecule)
results in reduced body size (Krishna et al., 1999; Savage
et al., 1996; Savage-Dunn et al., 2000; Suzuki et al., 1999;
Figures 7 and S6A). We found no degenerative phenotype in sin-
gle mutants (n > 100 animals analyzed), and all four mutations
significantly suppressed the degenerative phenotype in mec-
17(ok2109) mutants (Figure 7). To ensure that these modulating
effects were not due to underlying differences in the develop-
mental status of the long versus short animals, we performed
lifespan experiments. We found no correlation between body
morphology and lifespan (Figures S6C and S6D) and extended
these findings by analyzing degeneration in animals mutant for
daf-2, a receptor tyrosine kinase molecule that when mutated
causes a doubling in the lifespan of C. elegans (Kenyon et al.,
1993). The penetrance of axonal degeneration in mec-17; daf-2
double mutants was not significantly different from that in
mec-17 single-mutant animals (Figure S6E). These results reveal
an underlying role of the animal’s body morphology in the
capacity of the neuron to preserve axonal structure over time.
DISCUSSION
The axon frequently extends many times the length of the cell
body. As such, maintenance of the axonal structure over an
organism’s lifetime imposes considerable strain and requires
effective transport of organelles, specific molecules, and trophic
factors along the axonal shaft. In particular, cumulative evidence
supports a critical role for mitochondrial transport and function in
axonal maintenance (Court and Coleman, 2012). Furthermore,
maintenance of axonal structure is dependent on an intact
microtubule network that is not only vital for providing structural
support but also allows the movement of motor proteins, which
rely on themicrotubules for axonal trafficking (Falnikar and Baas,
2009). Our results identify the crucial contribution of MEC-17 in
preserving axonal structure and suggest a model in which(F) Penetrance of axonal degeneration in 3-day-old adult coel-1(gk1236),
mec-17(ok2109), or coel-1; mec-17 double mutants.
(G) Animals carrying the ky850 or mec-17(ok2109) mutations were paralyzed
bymicroinjection of unc-54 dsRNA and the penetrance of breaks compared to
that in nontreated animals.
The error bars represent SE (C and D) and SE of proportion (E–G); *p < 0.05;
**p < 0.01; ***p < 0.001; nR 100 animals for (E–G).
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Figure 7. Axon Degeneration Is Modulated
by Body Morphology in mec-17 Mutants
Schematics show percentage increase or
decrease in body length of 3-day-old adults
caused by mutations in different genes. Bar graph
represents the increase or decrease in the
penetrance of degeneration in mec-17(ok2109)
mutants when combined with body-elongating
mutations (lon-1(e185), lon-2(e678), lon-3(e2175),
lon-8(hu187)) or shortening mutations (dbl-1(nk3),
sma-3(e491), sma-4(e729), sma-6(e1482)).
The error bars represent SE of proportion; nR 160
animals.MEC-17 stabilizes themicrotubules to allow efficient binding and
movement of motor proteins, thus permitting correct transport of
mitochondria and other essential cargo throughout the axon.
The disrupted localization of UNC-104/kinesin-3, combined
with mislocalization of RAB-3 and mitochondria, suggest a role
for MEC-17 in maintaining efficient axonal transport. Mitochon-
dria are critical for axonal health, carrying out essential functions
in generating adenosine triphosphate, buffering intracellular
Ca2+ and reactive oxygen species, and synthesizing various
cellular components (Court and Coleman, 2012; Martin, 2012).
Efficient, long-distance transport of mitochondria relies upon
kinesin and dynein motor proteins, as well as the microtubule
tracks that guide them (Hollenbeck, 1996). MEC-17 is critical
for microtubule architecture (Cueva et al., 2012; Topalidou
et al., 2012), and here we show that, in the absence of mec-17,
microtubules are destabilized, axonal transport disrupted, and
axon segments furthest from the cell body become largely
devoid of mitochondria. The vast majority of axon breaks we
observed occurred within these mitochondria-barren regions,
suggesting that MEC-17 is required to keep a consistent distri-
bution and number of mitochondria for proper neuronal mainte-
nance. However, it is equally plausible that loss of axonal stability
in the absence of MEC-17 prevents the movement of mitochon-
dria out of the distal axon regions, leading to their degradation
and thus a reduction in their numbers.
Our data support a role for MEC-17 in stabilizing the microtu-
bules.We find a strong enhancement of microtubule dynamics in
animals mutant for mec-17, suggesting that loss of MEC-17
causes instability of the microtubule network, leading to exces-
sive microtubule turnover and more microtubules entering the
growth phase in compensation. Furthermore, axonal degenera-
tion and mitochondrial-distribution defects induced by the
absence of mec-17 could be strongly suppressed with a micro-
tubule-stabilizing drug and significantly enhanced bymild desta-
bilization. In addition, we found qualitatively similar, albeit more
severe, axonal degeneration phenotypes in animals lacking
MEC-12/a-tubulin and MEC-7/b-tubulin, and a genetic interac-
tion of mec-17 with mutations in either of these tubulins. Our100 Cell Reports 6, 93–103, January 16, 2014 ª2014 The Authorsgenetic analysis defines a synergic
role of MEC-17 with the tubulin-folding
cofactor-E-like molecule COEL-1, a
molecule related to a murine model of
motor neuron disease (progressive motorneuronopathy) characterized by progressive axonal degenera-
tion (Bommel et al., 2002).
Previous studies have shown that acetylation of a-tubulin does
not affect microtubule stability and that the acetyltransferase
domain of MEC-17 is not required for correct neurite outgrowth
or neuronal function (Perdiz et al., 2011; Cueva et al., 2012;
Topalidou et al., 2012). However, the enzymatic activity of
MEC-17 is required for regulating the organization and number
of microtubules and the protofilaments within them. Two recent
publications have made the surprising discovery that the micro-
tubules of fibroblasts with knockdown ofmec-17/aTAT1 expres-
sion, or derived fromMEC-17/aTAT1-null mice, show resistance
to the depolymerizing agent nocodazole (Kalebic et al., 2013a,
b). These results add to the growing intrigue of the MEC-17
molecule and may point toward cell-specific effects on microtu-
bule stability, with the molecule promoting stability in the
nervous system but acting to destabilize the microtubules
network in order to promote cytoskeletal rearrangements and
cell motility in other tissues. Our data showing that MEC-17
functions independently from its acetyltransferase domain in
preventing axonal degeneration support the notion of enzy-
matic-dependent and -independent functions, with MEC-17
binding within themicrotubule lumen and likely acting as a struc-
tural support to modulate microtubule organization (Cueva et al.,
2012; Topalidou et al., 2012). Whereas at present we cannot
exclude the existence of other domains capable of still-unidenti-
fied enzymatic activities, our study reveals a critical role for
MEC-17 in modulating microtubule stability and protecting
from axonal degeneration.
EXPERIMENTAL PROCEDURES
Strains
Strains were cultured under standard conditions (Brenner, 1974), and all exper-
iments were performed at room temperature (22C). The wild-type N2 Bristol
and CB4856 Hawaiian isolates and the following mutations were used:
LGII: sma-6(e1482); LGIII: daf-2(e1370), mec-12(u63), mec-12(u241), mec-
12(e1607), sma-4(e729), lon-1(e185), sma-3(e491); LGIV: mec-17(ok2109),
mec-17(u265), mec-17(ky850); LGV: dbl-1(nk3), lon-3(vd037), lon-3(e2175),
lon-8(hu187); and LGX: coel-1(gk1236), lon-2(e678), atat-2(ok2415), mec-
7(ok2152).
Transgenes used were: zdIs5(Pmec-4::GFP), vdEx267/vdEx539/vdEx546
(Pmec-4::mec-17 [10 ng/ml]; Plad-2::mCherry), vdEx484(Pmec-4::tomm-
20::mRFP [0.5ng/ml]; Punc-122::GFP [25 ng/ml]), jsIs1111(Pmec-4::unc-
104::GFP; a gift from Sandhya Koushika), vdEx262(Pmec-4::mCherry::rab-3
[0.5 ng/ml]; Punc-122::GFP [25 ng/ml]), vdEx411/vdEx543/vdEx548 (Pmec-
4::mec-17[D144N] [10 ng/ml]; Podr-1::dsRed [30 ng/ml]), juEx2843(Pmec-
4::EBP-2::GFP; a gift from Anindya Ghosh-Roy and Andrew Chisholm);
ekSi1(Pmec-12::mec-12::30 UTR mec-12) II; ekSi3(Pmec-12::mec-12
[K40R]::30 UTR mec-12) II (both were gifts from Jacek Gaertig).
Isolation of Mutants and Genetic Mapping
Animals of genotype zdIs5; sir-2.1(ok434) were mutagenized using 50 mM
ethyl methanesulfonate (Sigma) for 4 hr. The ky850 mutation was isolated
from a clonal F2 progeny screen, and the sir-2.1 mutation was found not to
influence the phenotype. These animals were crossed to wild-type CB4856
males, and single nucleotide polymorphism (SNP) mapping was performed
using 11 previously described SNPs per chromosome (Davis et al., 2005;
Wicks et al., 2001), which mapped the mutation to a central region on chromo-
some IV. The ky850 isolate was backcrossed 103 with the parental zdIs5;
sir-2.1 line, before whole-genome sequencing was conducted on each
(Australian Genome Research Facility), reaching a mean depth of 16.6–16.9.
The lon-3(vd037) allele consists of a 3,525 bp deletion spanning from the left
flank sequence 50-ttgccagagagagaaagttgacaaaacaat-30 to the right flank
sequence 50-tcctgttgggcaagtattctccacagtaca-30 and an insertion of 12 bp
(gggcaagtattc). Genotyping was performed using the following primers: outer
left 50-agagcacaatgacactctttcc-30; outer right 50-agatatccattgtcgttcttccc-30;
inner left 50-aagcaaatgaccgatcgacc-30; and inner right 50-tcacgtatgttgacaaata
tcagg-30.
Molecular Biology
Standard molecular biology techniques were used. The Pmec-4::mec-17
plasmid was generated by replacing the GFP sequence from the Pmec-
4::GFP plasmid with an XmaI/AgeI full-length genomic mec-17 sequence
(amplified from N2 genomic DNA using 50-atgcaagtcgacgccgacctcc-30 and
50-tcaccacaatggcttgctcgacag-30 primers). Pmec-4::tomm-20::mRFP was
created by replacing the myo-3 promoter from Pmyo-3::tomm-20::mRFP
(Ichishita et al., 2008) with an HindIII/XbaI Pmec-4 sequence (amplified from
Pmec-4::GFP using 50-aagcttcaatacaagctcaa-30 and 50-tctataacttgatagc
gata-30 primers). The Pmec-4::mCherry::rab-3 plasmid was created by replac-
ing GFP in Pmec-4::GFP with mCherry and subsequently inserting a FseI/AscI
rab-3 coding sequence downstream from mCherry. The rab-3 sequence was
amplified from the Prab3::eGFP::RAB3::rim-3 plasmid (a gift from Michael
Nonet, Washington University in St. Louis; using 50-gctggcggacaacctcaagg-30
and 50-ttagcaattgcattgctgttgagc-30 primers). QuikChange Site Directed Muta-
genesis (Agilent Technologies) was used to create the Pmec-4::mec-
17(D144N) plasmid, with Pmec-4::mec-17 used as the template and the
following primers: sense: 50- gaaccttatcaattggctcttaataatccatcagtcactcttc-30
and antisense: 50-gaagagtgactgatggattattaagagccaattgataaggttc-30.
To induce paralysis, P0 animals were microinjected with double-stranded
RNA (dsRNA) against unc-54, transcribed with a MEGAscript T7 In Vitro
Transcription Kit (Life Technologies) using a DNA template amplified from
N2 genomic DNA (with T7 tagged primers: 50-tgagcaacagctcaaggaga-30 and
50-acaaaaatagggggtgggag-30) and F1 progeny were analyzed.
Microscopy
Animals were immobilized using 0.05% tetramisole hydrochloride on 3% agar
pads, imaged with a Zeiss Axio Imager Z1 equipped with a Photometrics Cool
Snap HQ2 camera, and analyzed using Metamorph software.
Analysis of Microtubule Dynamics
EBP-2::GFP dynamics were analyzed similarly as previously described
(Ghosh-Roy et al., 2012). Animals were immobilized without anesthetics using
a suspension of 0.1 mm polystyrene beads on 12.5% agarose pads made with
M9. Live imaging was performed with a Yokogawa Confocal Scanner Unit
CSU-W1 attached to a Zeiss Axio Observer and fitted with a HamamatsuC11440-22C sCMOS camera (2,048 3 2,048, with 2 3 2 binning) and
Slidebook 5.5.4 software. EBP-2::GFP dynamics were captured with 114 ms
exposures captured every 230 ms for 200 frames. ImageJ 1.47u was used
to generate kymographs from the initial 25 mm of the PLM axon, from which
EBP-2::GFP tracks were manually traced to calculate their growth size and
duration (as shown in the schematic in Figure 6A). Only tracks that were
completely imaged and longer than 0.5 mm were analyzed. Catastrophe
frequency represents the ratio of the total number of tracks divided by the
duration of all growth events within the kymographs (Stepanova et al., 2010).
Phenotypic Analyses
Unless otherwise stated, all analyses were performed on 3-day-old adults.
Axonal breaks were only classified as breaks when a distal fragment was
visible; however, due to an increased rate of distal clearance in mec-12 and
mec-7 animals, degeneration was recorded when a distal fragment was
present or when the axons were significantly shorter than in wild-type animals.
Light-touch assays were performed as previously described (Chalfie and Sul-
ston, 1981). Scoring of mitochondria was performed in animals without axonal
degeneration, so as to eliminate bias caused by shortening of axons inmec-17
mutants with breaks. To determine the axonal positioning of mitochondria and
accumulation of UNC-104::GFP, the axon was divided into three equal-sized
segments using ImageJ 1.47u and labeled as proximal, central, and distal in
relation to the cell body. UNC-104::GFP pooling at the distal end was scored
when there was a clear accumulation of bright fluorescence, whereas axonal
accumulation was recorded when fluorescent puncta were at least twice as
bright as adjacent axon segments and when they caused the axon to at least
double in width. PLM posterior outgrowth was recorded as a defect when it
reached a length significantly longer than wild-type animals (greater than
approximately four cell-body lengths and frequently branched), and ALM pos-
terior outgrowth was considered a defect when the neurite was greater than
two cell bodies in length. Metamorph software was used to measure body
length, with the length of a central line from head to tail being recorded.
Drug Treatment
Animals were grown on nematode growth media (NGM) agar plates containing
0.1 mM colchicine (Sigma-Aldrich) or 1 mMpaclitaxel (Sigma-Aldrich) in DMSO
as previously described (Chalfie and Thomson, 1982; Kirszenblat et al., 2013).
For control plates, animals were grown with 1% DMSO. P0 animals were
grown from L4 stage on drug plates and their F1 progeny were scored.
Lifespan Analysis
Lifespan assays were conducted by transferring L4-stage animals to NGM
agar plates containing 0.1 mg/ml 5-fluoro-20-deoxyuridine (Sigma-Aldrich),
which causes sterility without affecting adult morphology or lifespan (Mitchell
et al., 1979). Animal viability was analyzed daily, with visualization of body
movement and pharyngeal pumping providing evidence of life and prodding
with a platinum wire pick used to confirm life or death in the absence of
these signs.
Statistical Analysis
Statistical analyses were performed using Primer of Biostatistics 3.01 and
Microsoft Excel 2011. Error of proportions was used to assess variation across
a single population, and two-way comparisons were performed using the
Student’s t test.
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